Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial. - sprookjes - yvandenbroek - TriplyDB

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.

http://www.wikidata.org/entity/Q31151097

about

Assessment of lower limb ischemia with measurement of skin perfusion pressure in patients on hemodialysis.Rheopheresis in patients with critical limb ischemia--results of an open label prospective pilot trial.A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome.The Difference Between the Healing and the Nonhealing Diabetic Foot Ulcer: A Review of the Role of the Microcirculation.Rheohemapheresis may be successful.Double filtration plasmapheresis in different diseases in Thailand.Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss.Therapeutic Apheresis in Metabolic Syndrome

P2860

Q33284441-8B9C923A-DB1E-43A3-A765-3BE93B461E07 Q34651421-636BBF54-F9C3-4806-9DB9-579615731160 Q37969137-1AF5E137-B8EC-4CEE-983C-9BD7AE41F257 Q38889796-93D25747-D44B-49E9-B79A-98C8C88933C4 Q42726744-95EFE309-EA94-4898-9687-AAA320C51030 Q45781215-AF442796-CC36-4AD8-8E99-DED33AA00436 Q46733527-7B758A05-29EB-481A-A6CC-22CF55039C9B Q58131385-F6E7BD0A-F446-4DB8-962F-4C13AAC57C57

P2860

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.

http://www.wikidata.org/entity/Q31151097

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Rheopheresis in patients with ...... label prospective pilot trial.

@ast

Rheopheresis in patients with ...... label prospective pilot trial.

@en

type

label

Rheopheresis in patients with ...... label prospective pilot trial.

@ast

Rheopheresis in patients with ...... label prospective pilot trial.

@en

prefLabel

Rheopheresis in patients with ...... label prospective pilot trial.

@ast

Rheopheresis in patients with ...... label prospective pilot trial.

@en

P1433

Q31151097-357E2D6C-514F-4A35-B5A4-3B08570F55F5

P1476

Q31151097-48410EB8-9B1B-46BA-99AB-FE8F40EC84B6

P2093

Q31151097-07547203-C043-403A-BC6A-F4BD3D065E0E

Q31151097-0E6FE3AC-CD48-4D9E-A9FA-97A54819ED0E

Q31151097-20CCD9F2-5621-4983-A2BD-D8F9A9FBB2F9

Q31151097-50D62514-AC1C-4AFA-9B47-917FC4CCC110

Q31151097-675FBB59-7B60-4559-A879-5EAE88648F2C

Q31151097-6ACE657A-A23A-4CE9-BC1D-A2AAFE85C9DD

Q31151097-9AABA0F8-D52E-4FDF-862C-2F24E45C8BAF

Q31151097-A5698284-7214-4F9A-A46E-C0B033195E95

Q31151097-F83B7EA5-0138-4205-B2F3-6978C3B268D0

P2860

Q31151097-1C14F3D5-D811-4C81-81BD-F17A5213D023

Q31151097-2AC22B5F-7762-446B-8431-273C3E193427

Q31151097-35E80B0A-550F-4F8E-94FC-40BAB6E6E7C5

Q31151097-73F63BB6-BCC6-4465-A29F-CCA38604247A

Q31151097-7555ABD4-61C2-47F8-904F-182369AAF3CE

Q31151097-819E2900-AA41-43B6-844F-BDA99D84F0DC

Q31151097-83C87B2D-0619-447A-B14A-405C0DFE4A12

Q31151097-910DDDC2-9539-433E-B47F-A1194438258D

Q31151097-B023127E-5548-42DC-8EEA-77F8955D2D6C

Q31151097-DC9342B5-22DC-4ED0-B453-BE4679FAE651

P304

Q31151097-DB8B9E1B-EF81-4192-B58F-716AAFFDF92F

P31

Q31151097-1963E295-ED34-4817-94A5-1E0CBBF21987

P356

Q31151097-6414830C-B200-45C7-A785-795007C80821

P433

Q31151097-64CAF480-1F7E-485D-8A66-009F141DB75A

P478

Q31151097-99CFF5B0-9150-4086-985E-105442AE8B7F

P577

Q31151097-DAB572B9-08F0-40ED-89EC-D2609196152E

P698

Q31151097-8812133E-B1E7-40AB-94CE-AEACC9F56A99

P356

J.1526-0968.2003.00082.X

P1433

Therapeutic Apheresis and Dialysis

P1476

Rheopheresis in patients with ...... label prospective pilot trial.

@en

P2093

Christian Mumme

http://www.w3.org/2001/XMLSchema#string

Ernst Küstner

http://www.w3.org/2001/XMLSchema#string

Frido Himmelsbach

http://www.w3.org/2001/XMLSchema#string

Johannes Lotz

http://www.w3.org/2001/XMLSchema#string

Jürgen Beyer

http://www.w3.org/2001/XMLSchema#string

Reinhard Klingel

http://www.w3.org/2001/XMLSchema#string

Thomas Pohlmann

http://www.w3.org/2001/XMLSchema#string

Thurid Fassbender

http://www.w3.org/2001/XMLSchema#string

Ulrich Altes

http://www.w3.org/2001/XMLSchema#string

P2860

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Improvement of macular function by membrane differential filtration in diabetic retinopathy.

Hyperbaric oxygen therapy and the diabetic foot.

Rheopheresis: rheologic, functional, and structural aspects.

Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up.

Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

Extracorporeal fibrinogen adsorption--efficacy, selectivity and safety in healthy subjects and patients with foot ulcers.

Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus.

P304

444-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1526-0968.2003.00082.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12887730

http://www.w3.org/2001/XMLSchema#string